Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen with or without Octreotide in Adjuvant Treatment of Breast Cancer
NCT00002864Phase 3Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Sep 1996
- Primary completion
- Dec 2007
- Modality
- Peptides
- Countries
- 2
01
Overview
A Phase 3 trial of octreotide in breast cancer, sponsored by Canadian Cancer Trials Group. Started Sep 1996; status: completed.
02
Drugs
octreotide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00002864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002864.